BMRN vs CUBE · P/E 40, rev $2.85B vs P/E 25, rev $1.07B
Biomarin Pharmaceutical Inc (BMRN) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BMRN and CUBE stock pages for the full models.
Not investment advice.